Repurposing rheumatology drugs for COVID-19: JAK inhibitors
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Repurposing rheumatology drugs for COVID-19: JAK inhibitors
-
Narrated by:
-
By:
About this listen
Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.
adbl_web_global_use_to_activate_webcro805_stickypopup
No reviews yet